Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.72 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.72 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.72 |
| ▸ | TSHR | P16473 | 1/20 | 0.72 |
| ▸ | ACHE | P22303 | 1/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.72 |
| ▸ | BLM | P54132 | 2/20 | 0.70 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.70 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.67 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 2/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | THRB | P10828 | 1/20 | 0.65 |
| ▸ | ATM | Q13315 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.65 |
| ▸ | SCN1A | P35498 | 1/20 | 0.62 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.62 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9508085 | 0.91 | LMNA (0.60) | LMNAALDH1A1SLC22A2SLC22A1TSHR | |
| SCHEMBL2442620 | 0.86 | LMNA (0.58) | LMNAALDH1A1SLC22A2SLC22A1TSHR | |
| SCHEMBL10195011 | 0.85 | LMNA (0.74) | LMNAALDH1A1SLC22A2SLC22A1TSHR | |
| SCHEMBL9254351 | 0.85 | ALDH1A1 (0.74) | LMNAALDH1A1SLC22A2SLC22A1TSHR | |
| Hydrochloric Acid SCHEMBL2444507 | 0.84 | LMNA (0.59) | LMNAALDH1A1SLC22A2SLC22A1TSHR | |
| SCHEMBL24185288 | 0.84 | LMNA (0.72) | LMNAALDH1A1SLC22A2SLC22A1TSHR | |
| SCHEMBL12438386 | 0.84 | POLB (0.84) | LMNAALDH1A1SLC22A2SLC22A1TSHR | |
| Procainamide SCHEMBL15914 | 0.84 | ALDH1A1 (1.00) | LMNAALDH1A1SLC22A2SLC22A1TSHR | |
| SCHEMBL9363810 | 0.84 | POLB (0.84) | LMNAALDH1A1SLC22A2SLC22A1TSHR | |
| SCHEMBL12845484 | 0.84 | LMNA (0.72) | LMNAALDH1A1SLC22A2SLC22A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116063141-B | Refining recovery method and device for residues in process of preparing isobutene from tertiary butanol | 北京水木信汇科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| US-20010006619-A1 | Compounds for cancer imaging and therapy | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 2001-07-05 | — | — | US | claimed |
| EP-0821594-A1 | COMPOUNDS FOR CANCER IMAGING AND THERAPY | JOHN, Christy S. (US) | 1998-02-04 | — | — | EP | claimed |
| WO-1996032968-A1 | COMPOUNDS FOR CANCER IMAGING AND THERAPY | JOHN CHRISTY S (US) | 1996-10-24 | — | — | WO | claimed |
| EP-0650372-A4 | COMPOUNDS FOR CANCER IMAGING AND THERAPY. | JOHN CHRISTY S (US) | 1996-07-03 | — | — | EP | claimed |
| EP-0650372-A1 | COMPOUNDS FOR CANCER IMAGING AND THERAPY | JOHN, Christy S. (US) | 1995-05-03 | — | — | EP | claimed |
| WO-1994026314-A1 | COMPOUNDS FOR CANCER IMAGING AND THERAPY | JOHN CHRISTY S (US) | 1994-11-24 | — | — | WO | claimed |
| EP-0458886-B1 | AGENTS FOR DIAGNOSING AND TREATING MELANOMAS, AROMATIC HALOGENATED DERIVATIVES USABLE AS SUCH AGENTS AND THEIR PREPARATION | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1993-10-13 | — | — | EP | claimed |
| US-20250335699-A1 | REWRITING TEXT USING MACHINE-LEARNED LANGUAGE MODELS AND PRESENTING REWRITTEN TEXT ON USER INTERFACE | TEXTIO INC (US) | 2025-10-30 | — | — | US | disclosed |
| CN-119564674-A | Application of vitamin C in preparation of medicine for treating thyroid injury and iron death caused by air fine particles | 新乡医学院 | 2025-03-07 | — | — | CN | disclosed |
| WO-2024141752-A1 | MAGNETICALLY GEARED SYSTEMS AND METHODS | MAGNOMATICS LIMITED (GB) | 2024-07-04 | — | — | WO | disclosed |
| US-20240093069-A1 | Activatable Polymer Composition Comprising At Least Two Carboxylic Acids as Blowing Agent | ZEPHYROS, INC. | 2024-03-21 | — | — | US | disclosed |
| EP-3710015-B1 | USE OF SRSF3 AGENTS FOR THE TREATMENT AND/OR PREVENTION OF NEUROLOGICAL CONDITIONS, CANCER, BACTERIAL INFECTIONS OR VIRAL INFECTIONS | UNIV LAVAL (CA) | 2024-01-17 | — | — | EP | disclosed |
| US-11834588-B2 | Activatable polymer composition comprising at least two carboxylic acids as blowing agent | ZEPHYROS, INC. (US) | 2023-12-05 | — | — | US | disclosed |
| EP-0650372-A4 | COMPOUNDS FOR CANCER IMAGING AND THERAPY. | JOHN CHRISTY S (US) | 1996-07-03 | — | — | EP | disclosed |
| EP-0656944-A1 | HUMAN MELANOCYTE STIMULATING HORMONE RECEPTOR | Wa Pharm AB (SE) | 1995-06-14 | — | — | EP | disclosed |
| EP-0650372-A1 | COMPOUNDS FOR CANCER IMAGING AND THERAPY | JOHN, Christy S. (US) | 1995-05-03 | — | — | EP | disclosed |
| WO-1994026314-A1 | COMPOUNDS FOR CANCER IMAGING AND THERAPY | JOHN CHRISTY S (US) | 1994-11-24 | — | — | WO | disclosed |
| WO-1994004674-A1 | HUMAN MELANOCYTE STIMULATING HORMONE RECEPTOR | WIKBERG JARL (SE) | 1994-03-03 | — | — | WO | disclosed |
| US-5190741-A | Aminopropyl Radioactive Iodobenzamides | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1993-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010006619-A1 | Compounds for cancer imaging and therapy | SIGMAR1, TMEM97, ADRB3 | LMNA 2715/4885ALDH1A1 713/4885SLC22A2 1000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.